Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Drug-induced linear immunoglobulin A bullous dermatosis: A French retrospective pharmacovigilance study of 69 cases.
Garel B, Ingen-Housz-Oro S, Afriat D, Prost-Squarcioni C, Tétart F, Bensaid B, Bara Passot C, Beylot-Barry M, Descamps V, Duvert-Lehembre S, Grootenboer-Mignot S, Jeudy G, Soria A, Valnet-Rabier MB, Barbaud A, Caux F, Lebrun-Vignes B. Garel B, et al. Br J Clin Pharmacol. 2019 Mar;85(3):570-579. doi: 10.1111/bcp.13827. Epub 2019 Jan 4. Br J Clin Pharmacol. 2019. PMID: 30511379 Free PMC article.
[National Campaign of Vaccination against the flu A (H1N1)v: National Follow-up of Pharmacovigilance].
Durrieu G, Caillet C, Lacroix I, Jacquet A, Faucher A, Ouaret S, Sommet A, Perault-Pochat MC, Kreft-Jaïs C, Castot A, Damase-Michel C, Montastruc JL; le réseau français des centres de pharmacovigilance. Durrieu G, et al. Therapie. 2011 Nov-Dec;66(6):527-40. doi: 10.2515/therapie/2011075. Epub 2011 Dec 21. Therapie. 2011. PMID: 22186078 Review. French.
Incidence of hospital admissions due to adverse drug reactions in France: the EMIR study.
Bénard-Laribière A, Miremont-Salamé G, Pérault-Pochat MC, Noize P, Haramburu F; EMIR Study Group on behalf of the French network of pharmacovigilance centres. Bénard-Laribière A, et al. Fundam Clin Pharmacol. 2015 Feb;29(1):106-11. doi: 10.1111/fcp.12088. Epub 2014 Sep 25. Fundam Clin Pharmacol. 2015. PMID: 24990220
Drugs and Sleep Apneas? A review of the French Pharmacovigilance database.
Linselle M, Montastruc F, Jantzen H, Valnet-Rabier MB, Haramburu F, Coquerel A, Gouraud A, Perault-Pochat MC, Bagheri H, Montastruc JL. Linselle M, et al. Therapie. 2015 Jul-Aug;70(4):347-50. doi: 10.2515/therapie/2014218. Epub 2015 Feb 16. Therapie. 2015. PMID: 25679185
Safety surveillance of influenza A(H1N1)v monovalent vaccines during the 2009-2010 mass vaccination campaign in France.
Caillet C, Durrieu G, Jacquet A, Faucher A, Ouaret S, Perrault-Pochat MC, Kreft-Jaïs C, Castot A, Montastruc JL; French Network of Pharmacovigilance Centres. Caillet C, et al. Eur J Clin Pharmacol. 2011 Jun;67(6):649-51. doi: 10.1007/s00228-010-0961-8. Epub 2010 Dec 14. Eur J Clin Pharmacol. 2011. PMID: 21153631 No abstract available.
First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.
Durrieu G, Palmaro A, Pourcel L, Caillet C, Faucher A, Jacquet A, Ouaret S, Perault-Pochat MC, Kreft-Jais C, Castot A, Lapeyre-Mestre M, Montastruc JL; French Network of Pharmacovigilance Centres. Durrieu G, et al. Drug Saf. 2012 Oct 1;35(10):845-54. doi: 10.1007/BF03261980. Drug Saf. 2012. PMID: 22967189
46 results